| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 387,114 | 397,999 | 373,784 | 721,430 | | Cost of Revenue | 472,171 | 687,382 | 473,985 | 971,218 | | | Gross Profit | (85,057) | (289,383) | (100,201) | (249,788) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 83,767 | 53,138 | 134,556 | 125,350 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 35,363 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (168,824) | (342,521) | (234,757) | (410,501) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 50,274 | 298,010 | 79,520 |
-
| | Earnings Before Interest And Taxes | (124,087) | (54,605) | (177,826) | (437,745) | | Interest Expense | 23,942 | 42,754 |
-
| 18,718 | | Income Before Tax | (148,029) | (97,359) | (177,826) | (456,463) | | Income Tax Expense | 20,883 | 21,262 | 584 | (6,004) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (168,912) | (118,621) | (178,410) | (450,459) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (168,912) | (118,621) | (178,410) | (450,459) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($168,912) | ($118,621) | ($178,410) | ($450,459) |
|
0.20% Nasdaq 
Income Statement
